Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer. - Wikidata - wikimedia - TriplyDB

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.

http://www.wikidata.org/entity/Q33648540

about

Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma.JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling

P2860

Q55177532-E58E4B1A-9DB9-475E-9A81-B1F8D4D541F6 Q58771847-CAE9477F-5E60-4951-B339-883D40390269

P2860

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.

http://www.wikidata.org/entity/Q33648540

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.

@ast

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.

@en

type

label

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.

@ast

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.

@en

prefLabel

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.

@ast

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.

@en

P1433

Q33648540-DAB4196C-07B2-49C5-95D9-35C8ADB8B5DD

P1476

Q33648540-45FC623A-987C-41D0-94E2-95E0F02E3552

P2093

Q33648540-0BE3EF51-7902-493A-BCB2-FFC3534B46DE

Q33648540-10B0F570-E9D1-4D51-BEC9-1303D49284AC

Q33648540-14E712EF-6FCE-4373-BA74-3557B339C03A

Q33648540-16C0D3C4-4DC1-4C7D-9F7A-02A8C35E8647

Q33648540-2BF72E1B-746F-483C-A553-BF642E1D5208

Q33648540-4B325027-AFF2-494E-A777-EC718D4153B7

Q33648540-5F29857E-E9C8-4547-A963-6F5A30ABEB30

Q33648540-C10F3C96-854A-476A-99B9-566DAF5750F3

Q33648540-C540FEB7-9217-4AAE-B28D-AA0B4DEF57D1

Q33648540-C5B0BBD2-F5C4-4D59-9CF2-D247596C33FF

P2860

Q33648540-0509F767-CE6E-4C38-B027-683A17F45C3D

Q33648540-114AA649-DCF2-493E-B86D-EEF8B20AB1D2

Q33648540-1CB6764B-7B02-469E-9730-86D9D4318D43

Q33648540-21D867FC-844A-4111-B11B-4031481C3D95

Q33648540-3E9B049C-230E-4954-A058-615A1A1FEEE8

Q33648540-4EBD8410-6F78-4F04-9E4D-5EFFCDC8FE79

Q33648540-6C6CF2F3-DD61-4403-982D-B26DB456331C

Q33648540-7DBF735E-46D9-4875-8991-5263CE22A265

Q33648540-8C1CB626-A7B6-4DA2-B8D1-7F1A56D23213

Q33648540-AF3C32CE-6B34-4111-8ED9-570353782B13

P304

Q33648540-9046CAF6-BBD0-4821-9F33-23B618296901

P31

Q33648540-439DB342-C942-4446-8101-FCD47435F45B

P356

Q33648540-024CE61A-1963-43D4-873C-4FEB65CDB1A4

P407

Q33648540-7C089C3F-2654-46E1-A8C1-AA37A4B404C8

P433

Q33648540-F9F58345-D7D1-4151-9AB7-5750C43D5696

P478

Q33648540-3628F770-7F66-4806-AF09-7B51006B7C4B

P50

Q33648540-E972F728-C9A3-4CDF-8ECE-181C95372F58

P577

Q33648540-83E7D1C2-DEBC-43C4-B1AA-6FA812F42157

P698

Q33648540-B821F361-283E-46E0-8B2C-7E698D61167E

P921

Q33648540-B88841A2-E601-4CF9-A31C-28FA1DAC06CA

P932

Q33648540-29ABDB74-C58D-4C93-9E25-5FCBA77345F5

P356

ONCOTARGET.15522

P1433

P1476

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer

@en

P2093

Chun-Zhi Ai

http://www.w3.org/2001/XMLSchema#string

Gen-Shen Zhong

http://www.w3.org/2001/XMLSchema#string

Guangyao Li

http://www.w3.org/2001/XMLSchema#string

Min Niu

http://www.w3.org/2001/XMLSchema#string

Shan Jiang

http://www.w3.org/2001/XMLSchema#string

Shan-Shan Xu

http://www.w3.org/2001/XMLSchema#string

Shaojun Tang

http://www.w3.org/2001/XMLSchema#string

Shaoqi Tian

http://www.w3.org/2001/XMLSchema#string

Xiang-Zhen Wang

http://www.w3.org/2001/XMLSchema#string

Xin-Xing Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells

Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis.

Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells

Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells

Jarid2 and PRC2, partners in regulating gene expression.

Cancer stem cells in bladder cancer: a revisited and evolving concept

Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin.

JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines.

P304

24483-24490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.15522

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28445934

http://www.w3.org/2001/XMLSchema#string

P921

maternal health

P932

5421864

http://www.w3.org/2001/XMLSchema#string